Lasa Supergenerics Limited — Capital/Financing Update 2021

Jul 26, 2021

==> picture [452 x 69] intentionally omitted <==

Ref. No.: LASA/SE/21-22/20

Monday, July 26 2021

To, Corporate Services Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. BSE CODE –540702	To, Corporate Services Department National Stock Exchange of India Limited “Exchange Plaza”, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051. NSE CODE: LASA

Sub. : Press Release

Dear Sir,

Attached is a copy of Press Release tilted “ No Casualty in any of company’s units. Production to recommence in couple of Weeks.” Issued by the company.

You are requested to note the above on your records.

THANKING YOU YOURS SINCERELY FOR LASA SUPERGENERICS LIMITED

==> picture [471 x 67] intentionally omitted <==

NIDHI KULSHRESHTHA COMPANY SECRETARY AND COMPLIANCE OFFICER

==> picture [464 x 18] intentionally omitted <==

Lasa Supergenerics Limited CIN: L24233MH2016PLC274202

==> picture [115 x 60] intentionally omitted <==

Media Release

Update of Recent incidents

No Casualty in any of company’s units.

Production to recommence in couple of Weeks.

Mumbai, July 26, 2021: Lasa Supergenerics Limited (BSE: 540702, NSE: LASA), pioneer and amongst the leading players in the manufacturing of Veterinary APIs in India through its catalyst chemistry expertise and fully backward integrated unit, has faced with some untoward incidences in the form of a unfortunate fire at its unit in Mahad and also natural calamity in the form of floods at its Chiplun Units.

No casualty reported in any of the units.

Management Comments:

Commenting on the recent development, Dr. Omkar Herlekar, Chairman & Managing Director, Lasa Supergenerics Limited said:

“This is a very challenging phase for us. Since we are in an industry that deals with highly inflammable chemicals and processes, we ensure to follow every possible guideline and take every necessary & cautionary step to keep ourselves and our plants safe. The safety of our staff and of our assets is our primary concern every day. I feel very relieved that every life has been protected in both incidents - the fire and flood at our plants. Since we are full of order book we cannot afford to lose even a single customer or order hence by hook or crook we shall be back stronger at the earliest. I assure stakeholders that we will take every necessary step to come back stronger and also urge not to panic as things are under control and we are confident to recommence immediately .

Good times and bad times both are part of our lives, at this time we are looking forward to recommence all our operations within couple of weeks even with more enthusiasm, our management leave no stone unturned to achieve earliest commencement by striving hard day in out since the day of this unfortunate incidents. We will take all necessary steps to reduce any prospective damage from this natural calamity.

Lasa Supergenerics Limited CIN: L24233MH2016PLC274202

==> picture [115 x 60] intentionally omitted <==

At this juncture I would like to thank our management team, our suppliers who came forward to support in this testing times so that we can restart our operations at the earliest.

I sincerely thank the entire team of ‘LASA’ for their untiring efforts, hard work, sincerity and high dedication. Also, I would like to thank our valued Shareholders, whose support and faith in our Company has given us the determination and ambition to go from strength to strength.”

About Lasa Supergenerics Limited:

Lasa Supergenerics Limited is a globally well trusted brand with high quality products, accepted by large companies across the globe. The Company is a pioneer and amongst the leading players in the manufacturing of Veterinary APIs, with a well-established brand known for its high-quality products amongst various customers. It specializes in ‘catalyst chemistry’ and manufactures anthelmintic / veterinary API. To efficiently control the supply chain, the company has backward integrated its key molecules. The Company has its unit with state of art manufacturing facilities located at Mahad & Chiplun, Maharashtra. The Company exports APIs to counties like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea, Pakistan etc.

For more details please visit: www.lasalabs.com For any Investor Relations query, please contact:

Mr Hitesh Wadhwani

Lasa Supergenerics Limited

Email: hitesh@lasalabs.com

Note: Certain statements in this document may be forward-looking statements. Such forwardlooking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties and other risk factors, viewers are cautioned not to place undue reliance on these forward-looking statements. Lasa Supergenerics Ltd. will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.